Mori, K.; Matsumoto, K.; Amano, N.; Koguchi, D.; Shimura, S.; Hagiwara, M.; Shimizu, Y.; Ikeda, M.; Sato, Y.; Iwamura, M.
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer. Cancers 2022, 14, 1576.
https://doi.org/10.3390/cancers14061576
AMA Style
Mori K, Matsumoto K, Amano N, Koguchi D, Shimura S, Hagiwara M, Shimizu Y, Ikeda M, Sato Y, Iwamura M.
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer. Cancers. 2022; 14(6):1576.
https://doi.org/10.3390/cancers14061576
Chicago/Turabian Style
Mori, Kohei, Kazumasa Matsumoto, Noriyuki Amano, Dai Koguchi, Soichiro Shimura, Masahiro Hagiwara, Yuriko Shimizu, Masaomi Ikeda, Yuichi Sato, and Masatsugu Iwamura.
2022. "Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer" Cancers 14, no. 6: 1576.
https://doi.org/10.3390/cancers14061576
APA Style
Mori, K., Matsumoto, K., Amano, N., Koguchi, D., Shimura, S., Hagiwara, M., Shimizu, Y., Ikeda, M., Sato, Y., & Iwamura, M.
(2022). Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer. Cancers, 14(6), 1576.
https://doi.org/10.3390/cancers14061576